06/03/2023

INTRODUCING HEAT2MOVE: A NON-MEDICAL AND NON-INVASIVE PAIN RELIEVING TECHNOLOGY

PRESS RELEASE March 6, 2023 HEAT2MOVE, an NLC venture, sets out to provide a home care chronic pain relief option that is based on…

Read more
28/02/2023

INTRODUCING ANSANA: A NEW STERILIZATION TECHNOLOGY FOR THE HEALTHCARE & PHARMACEUTICAL INDUSTRY.

PRESS RELEASE February 28, 2023 Ansana, an NLC venture, is on a mission to develop and launch a cutting-edge system for observing and confirming…

Read more
27/02/2023

INTRODUCING CAREBED: A MOBILE-FRIENDLY SOLUTION FOR THE ELDERLY

PRESS RELEASE February 27, 2023 Carebed, an innovative bed that will increase a patient’s quality of life and reduce healthcare costs. Being dependent on…

Read more
23/02/2023

SERDA therapeutics submits IND

PRESS RELEASE February 23, 2023 SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent. SERDA therapeutics, a biopharmaceutical company, announces…

Read more
15/02/2023

NC BIOMATRIX WINS EIC GRANT

PRESS RELEASE February, 15 2023 NC Biomatrix receives €2.5M European Innovation Council funding to complete pre-clinical studies and run its first-in-human trial Hundreds of…

Read more
15/02/2023

MINDAFFECT AWARDED EUROSTARS GRANT

PRESS RELEASE February 15, 2023 MindAffect awarded Eurostar Grant for MAHDs – a groundbreaking EEG based Hearing Diagnostic System With approximately 175 million disabled…

Read more
30/01/2023

NLC LAUNCHES FIRST IMPACT REPORT

PRESS RELEASE January 30, 2023 NLC is proud to announce their first Impact Report Regardless of their importance or creativity, 95% of all healthtech…

Read more